Influenza Vaccination May Reduce Risk of Acute MI


Share this content:
Among other secondary prevention methods for MI, the influenza vaccine is within a similar efficacy range.Among other secondary prevention methods for MI, the influenza vaccine is within a similar efficacy range.
Influenza vaccination for patients with cardiovascular disease is underutilized as a method of coronary prevention, according to a review published in Heart.1
The authors noted there is “compelling evidence” linking influenza infection and the occurrence of acute myocardial infarction (MI)—in some cases, as early as within the first 3 days of an influenza respiratory illness and lasting up to 1 year./.../